Protective effects of Spirulina maxima on hyperlipidemia and oxidative-stress induced by lead acetate in the liver and kidney by Ponce-Canchihuamán, Johny C et al.
RESEARCH Open Access
Protective effects of Spirulina maxima on
hyperlipidemia and oxidative-stress induced by
lead acetate in the liver and kidney
Johny C Ponce-Canchihuamán
1, Oscar Pérez-Méndez
2, Rolando Hernández-Muñoz
3, Patricia V Torres-Durán
1,
Marco A Juárez-Oropeza
1*
Abstract
Background: Oxidative damage has been proposed as a possible mechanism involved in lead toxicity, specially
affecting the liver and kidney. Previous studies have shown the antioxidant effect of Spirulina maxima in several
experimental models of oxidative stress. The current study was carried out to evaluate the antioxidant activity of
Spirulina maxima against lead acetate-induced hyperlipidemia and oxidative damage in the liver and kidney of
male rats. Control animals were fed on a standard diet and did not receive lead acetate (Control group).
Experimental animals were fed on a standard laboratory diet with or without Spirulina maxima 5% in the standard
laboratory diet and treated with three doses of lead acetate (25 mg each/weekly, intraperitoneal injection) (lead
acetate with Spirulina, and lead acetate without Spirulina groups).
Results: The results showed that Spirulina maxima prevented the lead acetate-induced significant changes on
plasma and liver lipid levels and on the antioxidant status of the liver and kidney. On the other hand, Spirulina
maxima succeeded to improve the biochemical parameters of the liver and kidney towards the normal values of
the Control group.
Conclusions: It was concluded that Spirulina maxima has protective effects on lead acetate-induced damage, and
that the effects are associated with the antioxidant effect of Spirulina.
Background
The lead is a xenobiotic, persistent toxic [1,2], as other
xenobiotics induces to different health risks since the
fetal stage until senescence. On the other hand,
although lead is one of the most useful metals, it is also
one of the most toxic ones [3]. Also, both occupational
and environmental exposures remain a serious problem
in many developing and industrializing countries [4].
Several reports have indicated that lead can cause neu-
rological, hematological, gastrointestinal, reproductive,
circulatory, and immunological pathologies, all of them
r e l a t e dt ot h ed o s ea n dt h ea m o u n to ft i m eo fl e a d
exposure [5-8]. Also, the health risks occasioned by
exposure to lead are considered public health problems
at a world level.
The liver plays a major role in lead’s metabolism, and it
is in special risk due to the oxidative action of this xeno-
biotic; given the unquestionable evidence that lead-
induced lipid peroxidation of cellular membranes, plays a
crucial role in the mechanisms of hepatotoxic action of
these xenobiotics [9]. On the other hand, lead is known to
also affect the kidney, which is another important target
[10]. Lead produces oxidative damage in the kidney as evi-
denced by enhancing lipid peroxidation (LIP) [11,12].
In vivo and in vitro studies suggest that lipid metabo-
lism is altered both in acute and chronic exposure to lead
[13]. Lead inhibits antioxidant enzyme activity, such as
superoxide dismutase and catalase, and also decreases
the level of glutathione, increasing lipid peroxidation
[14,15], which harms proteins, cell membranes and DNA,
among others. However, this damage could decline when
antioxidants such as flaxseed are supplied [16].
The cyanobacterium Spirulina maxima or Arthrospira
maxima has shown hepatoprotective effects in rats, and
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demonstrated hypolipemiant and antioxidant effects of
the Spirulina in humans [18,19]. In addition, Spirulina
is a source of b-carotene, a-tocopherol, and phycocya-
nin, molecules with antioxidant properties [20-22].
Heavy metal poisoning like lead cause adverse effects
to hepatic cells because after lead exposure, liver is one
of the major organs involved in the storage, biotransfor-
mation and detoxification. Lead also, affects the kidney,
which is another important organ that participates in
the detoxification. The aim of the current study was to
evaluate the effects of Spirulina maxima on lipid meta-
bolism and the antioxidant system in the hepato and
nephrotoxicity induced by lead.
Materials and methods
Reagents, chemicals and Spirulina
All reagents and chemicals used were of analytical
grade. Lead acetate (LA) was purchased from Sigma
Chemical Co. (St. Louis, MO, USA). Powdered Spirulina
maxima used in the experimental diet was purchased
from Alimentos Esenciales para la Humanidad (Mexico)
and was free of lead. Total cholesterol (TC), triacylgly-
cerols (TAG) and alanine aminotransferase (ALT) were
assessed by enzymatic kits (Spinreact, Mexico). Total
lipids (TL) of the liver were extracted with 20 volumes
of chloroform/methanol (3:1, v/v; Merck, Mexico).
Experimental animals
Two-month old Wistar male rats (180-200 g) were
maintained and housed in a room with a controlled
temperature (12-15°C), artificially illuminated with dark-
light cycles (07:00 to 19:00 h as light). After an acclima-
tization period of one week, the animals were divided at
random into three groups (6 rats/group) and housed in
filter-top polycarbonate cages. All the animals received
humane care in compliance with the guidelines of Ani-
mal Care [23].
After lead exposure, the animals were observed inter-
daily for signs of toxicity. Body weight was recorded
inter-daily during the experimental period. The standard
laboratory food for rodents (Purina, Mexico) with or
without Spirulina 5% was used to feed all the animals
(diets Spirulina and without-Spirulina, respectively).
The amount of diet provided was 20 g/day/rat, water
was supplied ad libitum. Lead acetate treatment was
given to the experimental groups, three times (25 mg/
rat, weekly). Isotonic saline was used as a vehicle
(0.5 mL, i.p.), and given to the Control group as for the
experimental groups.
Experimental design
Animals within different treatment groups were main-
tained on their respective diets, followed for 30 days and
received the dose of LA the days 14, 21, and 28 as fol-
lows: Group 1 (untreated, Control) fed on Purina diet
and three doses of isotonic saline, i.p. Group 2 (LA trea-
ted, LA without Spirulina: LAwS) fed on Purina diet
and three doses of 25 mg of lead acetate, i.p. Group 3
(LA treated, LA Spirulina:L A S )f e do nSpirulina diet
and three doses of 25 mg of lead acetate, i.p.
At the end of the experimental period of 30 days, the
rats were deprived of food overnight by 12 hours and all
the animals were killed by cervical dislocation at 24 h
post-treatment, after being anaesthetized in a gas ether
atmosphere. Blood was collected by exsanguination in
h e p a r i n i z e dt e s tt u b e s .P l a sma was separated by centri-
fugation and stored at -78°C until lipid analyses were
performed. The ALT analyses were performed using
fresh plasma. The liver and the kidney were finely
excised and weighed. A segment of 1 g fresh liver was
removed for total lipids analyses. The enzyme activity of
superoxide dismutase (SOD) and catalase (CAT), as well
as the reduced glutathione (GSH) and thiobarbituric
acid-reactive substances (TBARS) levels were assessed
with fresh liver homogenate and fresh kidney homoge-
nate. The TBARS levels were reported in concentrations
of malondialdehyde (MDA).
Lipid analyses
Determinations of TC and TAG were made using com-
mercial colorimetric enzymatic methods, following the
recommendations by the providers.
For the liver and the kidney samples, 1 g of tissue was
homogenized in phosphate buffer; and the total lipids
were extracted with chloroform/methanol mixture by a
modified Folch’s method [24], and were determined
gravimetrically.
Alanine aminotransferase analysis
The level of ALT was assessed using commercial
method at 340 nm.
Antioxidant status indicators
The enzyme activity of SOD [25], and CAT [26], as well
as the GSH levels [27] were assessed in the liver and
kidney homogenates. Lipid peroxides from the liver and
kidney homogenates were measured by the determining
of TBARS formation [28].
The activity of SOD was determined by the Kono’s
method [25], through the capability of inhibition of
NBT (nitroblue of tetrazolium) reduction. The changes
in the absorbance were recorder at 560 nm during five
minutes.
The activity of CAT was determined by the Aebi’s
method [26], through the disappearance of H2O2.T h e
changes in the absorbance were determined at 240 nm
during five minutes.
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Owens [27]; previously, the sample homogenates were
mixed with 28% trichloroacetic acid (TCA, w/v) in order
to discard the protein fraction. The supernatant content
of GSH was performer using 5,5’-dithiobis (2-nitroben-
zoic acid) at 412 nm.
Products of lipid peroxidation were determined by the
Ohkawa’s method [28]; briefly, the free protein superna-
tant fraction was used to evaluate the TBARS produc-
tion [1]. The absorbance of the resulting chromophore
was determined at 535 nm, and expressed as MDA pro-
duction, using 1,1,3,3-tetraethoxypropane as standard.
Total protein content was assessed using Bradford’s
method [29], using albumin as standard at 595 nm.
The above-mentioned endogenous antioxidant indica-
tors were evaluated using a Genesis UV10 spectrophot-
ometer (Thermo Electron Co, USA), and their values
were expressed by protein content.
Statistical analysis
Results were evaluated statistically using one-way ana-
lyses of variance (ANOVA) with Bonferroni test of the
Statistical Package for the Social Sciences (SPSS, v. 16).
The significance of the differences among treatment
groups, to all statements of significance were based on
the probability of p < 0.05.
Results
Body weight of rats
The effect of Spirulina maxima (Sm) and lead acetate
on animal body weight gain in the different treatments
revealed that lead acetate (LAwS) alone significantly
decreased the body weight (p < 0.05). Then, at the end
of the experiment, body weight gain in the LAS group
(50.94 ± 5.23 g) was similar to the Control group (52.36 ±
4.51 g), but the LAwS group (47.41 ± 3.83 g) gained less
weight than the Control group (p < 0.05).
Determination of lipids in plasma and liver
As shown in Table 1, in both plasma and liver, TC and
TAG levels were higher in the LAwS group compared
to the Control group (p < 0.05). The LAS group showed
similar results to the Control group but significantly
lower TC and TAG levels than the LAwS group (p <
0.05). The total lipids in liver were similar levels among
the three groups.
Evaluation of ALT activity
The LAwS group showed higher ALT activity than the
Control (p < 0.05) and LAS (p < 0.05) groups. On the
other hand, the LAS group presented similar activity to
the Control group (Table 1).
Evaluation of the antioxidant status indicators
In the liver:
It was found that the enzyme activities of SOD and
CAT in rat liver were lower in LAwS group compared
to the Control (p < 0.05). The LAS group showed simi-
lar activities compared to the Control group but signifi-
cantly higher activities than the LAwS group (p < 0.05)
(Fig. 1).
The level of GSH in the liver was lower in the LAwS
g r o u pc o m p a r e dt ot h eC o n t r o l( p<0 . 0 5 )a n dt h eL A S
(p < 0.05) groups. The LAS group presented similar
GSH levels compared to the Control group (Fig. 1).
The level of MDA in rat liver was 1.51 and 1.42 times
higher in the LAwS group than the Control (p < 0.05)
and LAS (p < 0.05) groups, respectively. The LAS group
presented a similar MDA level compared to the Control
group (Fig. 1).
In the kidney:
It was found that the enzyme activities of SOD and
CAT in rat kidney were decreased in LAwS group com-
pared to the Control group (p < 0.05). The LAS group
showed similar activity of SOD and CAT compared to
Table 1 Effects of Spirulina maxima on biochemical parameters during sub-chronic lead exposure in rats.
Experimental Groups
Variable Control LAwS LAS
Aminotransferase
Alanine aminotransferase (ALT) (U/L)
a 28.76 ± 5.84 46.51 ± 4.04
b 31.72 ± 4.72
c
Plasma Lipids (mg/dL)
Total Cholesterol (TC)
a 80.07 ± 2.54 107.83 ± 2.69
b 82.99 ± 12.70
c
Triacylglycerols (TAG)
a 91.13 ± 2.45 125.24 ± 4.43
b 94.35 ± 5.09
c
Liver Lipids (μg/mgLip)
Total Cholesterol (CT)
a 133.49 ± 10.73 174.18 ± 13.13
b 134.32 ± 10.76
c
Triacylglycerols (TAG)
a 65.05 ± 6.84 197.93 ± 9.05
b 70.25 ± 11.22
c
Total Lipids (TL) (mgLip/g Liver) 48.98 ± 2.38 52.47 ± 3.27 49.40 ± 3.28
Values are mean ± SD (n = 6); in each group. LA (Lead acetate, 75 mg). Control (no LA and without Spirulina), LAwS (LA without Spirulina); LAS (LA with Spirulina)
ap < 0.05, Significantly different. ANOVA.
bp < 0.05, LAwS group compared with the Control group. Bonferroni test.
cp < 0.05, LAwS group compared with the LAS group. Bonferroni test.
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pared to the LAwS group (p < 0.05) (Fig. 2).
The level of GSH in kidney was lower in LAwS group
compared to the Control (p < 0.05) and LAS (p < 0.05)
groups. The LAS group presented a similar GSH level
compared to the Control group (Fig. 2).
The level of MDA in the rat kidney was 1.44 and 1.43
folds higher in the LAwS group compared to the Con-
trol (p < 0.05) and LAS (p < 0.05) groups, respectively.
The LAS group presented a similar MDA level com-
pared to the Control group (Fig. 2).
Discussion
In the present study, the role of Sm on hyperlipidemia
and oxidative damage in LA toxicity of liver and kidney
w a si n v e s t i g a t e di nm a l eW i s t a rr a t s .T h ed o s eo fL A
was based on literature reports [30] and on preliminary
studies. The lead exposure was of the sub chronic type.
The i.p. route was chosen because it is less stressful to
rats, and also because the concentration of lead in the
blood could reach levels considered toxic to humans
[31]. The dose of Sm was based on previous work [32].
The results indicated that the animals treated with LA
(LAwS) showed a decrease in body weight gain; similar
observations were reported by El-Nekeety et al [11].
Also, it was found that the mean body weight of the ani-
mals treated with LA (LAwS) was lower compared to
the Control and LAS groups.
The liver is considered one of the target organs
affected by lead toxicity owing to its storage in the liver
Figure 1 Effects of Spirulina maxima on liver oxidative status indicators during lead exposure in rats. The animals were treated with a
vehicle or with 75 mg of lead acetate (LA, 25 mg/0.5 ml isotonic saline each, i.p., and three times on days 14, 21 and 28, and sacrificed on day
30). Values are expressed in mean ± SD of n = 6 rats. (A). The total Superoxide Dismutase (SOD) activity. (B). The Catalase (CAT) activity. (C). The
Glutathione (GSH) levels. (D). The Thiobarbituric Acid-Reactive Substances (TBARS) levels. Control (no LA and without Spirulina), LAwS (LA without
Spirulina), LAS (LA with Spirulina). *p < 0.05, LAwS group compared with the Control group. ANOVA with Bonferroni test. **p < 0.05, LAwS group
compared with the LAS group. ANOVA with Bonferroni test.
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major organs involved in the storage, biotransformation
and detoxification of toxic substances, is of interest in
heavy metal poisoning [33]. The activity of ALT is one
of the indicators of hepatotoxicity [34]; in the present
study, treatment with LA (LAwS) induced a slight but
significant increase of ALT compared to the other
groups. On the other hand, the results also showed that
the LA significantly increased plasma levels of CT and
TAG in the LAwS group compared with the other
groups. The increased levels of lipids with increased
levels of ALT may indicate liver dysfunction [35]. These
results showed that the exposure to lead affects hepatic
tissue, which is consistent with other reports [36,37].
Lead is a heavy metal that produces oxidative damage
in the liver by enhancing lipid peroxidation (LIP) [11].
Lead toxicity leads to free radical damage by two sepa-
rate, although related, pathways: (1) the generation of
reactive oxygen species (ROS), including hydroperoxides,
singlet oxygen, and hydrogen peroxides, evaluated by
MDA levels as the final products of LIP, and (2) the
direct depletion of antioxidant reserves [16]. In the pre-
sent study, treatment with LA (LAwS) resulted in a sig-
nificant increase of LIP as indicated by the significant
increase of MDA levels and the significant decrease of
GSH levels. Our results are in agreement with other pre-
vious studies [16,2,38]. The presence of LIP observed in
the current study was also due to decreased SOD and
Figure 2 Effects of Spirulina maxima on kidney oxidative status indicators during lead exposure in rats. The animals were treated with a
vehicle or with 75 mg of lead acetate (LA, 25 mg/0.5 ml isotonic saline each, i.p., and three times on days 14, 21 and 28, and sacrificed on day
30). Values are expressed in mean ± SD of n = 6 rats. (A). The total Superoxide Dismutase (SOD) activity. (B). The Catalase (CAT) activity. (C). The
Glutathione (GSH) levels. (D). The Thiobarbituric Acid-Reactive Substances (TBARS) levels. Control (no LA and without Spirulina), LAwS (LA without
Spirulina), LAS (LA with Spirulina). *p < 0.05, LAwS group compared with the Control group. ANOVA with Bonferroni test. **p < 0.05, LAwS group
compared with the LAS group. ANOVA with Bonferroni test.
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T h ep o s s i b l ee x p l a n a t i o nc o u l db er e l a t e dt ot h ep r o -
posed role of GSH in the active excretion of lead through
bile by binding to the thiol group of GSH and then being
excreted. A decrease in GSH levels could lead to oxida-
tive stress and a consequent increase in LIP [2,11].
Lead is known to adversely affect many organs, where
the kidney is another of the important targets [10]. Lead
produces oxidative damage in the kidney, by enhancing
LIP [11,12]. In the present study, treatment with LA
(LAwS) resulted in a significant increase of LIP as indi-
cated by the significant increase of MDA levels and the
significant decrease of GSH levels. Similar results have
been reported [12,38-40]. The observed LIP in the cur-
rent study may also assume that there was a disruption
of prooxidant/antioxidant balance in lead exposure.
However, the source of prooxidant formation during
lead-induced oxidative stress has not been extensively
studied [10,41]. In addition, it has been reported that
the δ-aminolevulinic acid dehydratase (ALAD) inhibition
may result in the accumulation of ALA (aminolevulinic
acid), and accumulated ALA has been involved in lead-
induced oxidative damage by causing formation of reac-
tive oxygen species [42]. It is reasonable to speculate
that the increased LIP found in the present study was
triggered by ALA accumulation resulting from lead-
induced ALAD inhibition.
Lead also induces oxidative damage to the membranes
by the accumulation of oxidant metabolites (such as ALA,
free protoporphyrins, heme and iron ions) and by direct or
indirect inhibition of antioxidant enzymes, reducing the
total antioxidant protection of the cell, affecting mem-
brane structure and function and altering physiological
processes of organs and tissues [43]. These damages are
reflected in cellular structural changes and explain the
close relationship between the morphological changes
found in the kidneys of lead exposed animals with the
molecular and physiological changes with respect to the
TBARS levels showed by Navarro-Moreno et al [40].
The present results clearly indicate that the informed
biochemical determinations (metabolism of lipids and
antioxidant system) [2,11,35] provide evidence of lead
toxicity in liver and kidney, and also, the protective
effects of Sm as reported in other studies [17,19]. On
the other hand, the Sm does not induce any harmful
effects on the animals [44,45]. Rather, Sm succeeded to
induce an improvement in body weight and the bio-
chemical parameters. Several reports have indicated that
Sm has antihyperlipemic [17,18,46] and antioxidant
[19,46,47] effects due to its higher content of some
macro- and micronutrients including high quality pro-
tein, iron, gamma-linolenic fatty acid, carotenoids, vita-
mins B1 and B2 [48] b-carotene, a-tocopherol and
phycocyanin [20]. The phycocyanin has been considered
the predominant compound in the antioxidant activity
of the Spirulina [21,22].
In this study, co-treatment of LA and Sm (LAS)
resulted in a significant improvement of all biochemical
parameters tested of the plasma, liver, and kidney.
Therefore, this cyanobaterium may play a protective role
against LA-mediated liver and kidney injury in sub-
chronic exposure. These results demonstrated that Sm
has antihyperlipemic and antioxidant properties.
Conclusions
This study has demonstrated that exposure to lead could
have generated oxidative stress which resulted in the ele-
vation of lipids both in plasma and liver, as well as lipid
peroxidation in the liver and kidney associated with the
reduction in the antioxidant status. Spirulina maxima
co-treatment resulted in the prevention of the lead-
induced damages. The protective effects of Spirulina
maxima may be due to the radical scavenging activity of
its components. Consequently, Spirulina maxima could
be useful in the preventive treatment of lead toxicity.
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